We are looking to buy into weakness today, even though the market has gotten significantly tougher over the past few days.
Today, at Aegon's first interactive webinar for analysts and investors, CFO Matt Rider will detail the company's ongoing actions to deliver on its financial transformation, approach to capital management and prioritization in capital deployment.
Don't count on it. The fundamentals paint two very different pictures, Cramer says.
Jim discusses Comcast's offer for Fox, Kohl's, Amazon, 3M, JPMorgan, Goldman Sachs, Citigroup and more!
- Thomas C. Freyman to Join Allergan plc Board of Directors -
-An investigational implant being developed as the first sustained-release drop-free treatment option for patients-
Markets look calm, but we're seeing some extraordinary breakouts, says Jim Cramer.
You should be thinking positively these days if your stock has had a run or even if it hasn't as a preponderance of good things is liable to happen.
- Study meets primary endpoint for all doses and dose regimens -
We exited one stock, entered another, raised our price target on Kohl's and downgraded Nordstrom.
Markets bathed in the afterglow of the strong jobs report for most of the week.
A healthcare bill supported on both sides of the aisle was held up until Sen. Chuck Grassley talked with pharma companies.
Stocks finished mixed on Thursday as concerns mount over the potential for a major rift on trade and tariffs when G-7 leaders meet later this week.
Know Your Birth Control® Launches New 'BC Trivia' Quiz to Encourage Informed Conversations Around Contraception
U.S. stock futures are higher on Thursday and stocks in Europe and Asia extend gains; Jamie Dimon and Warren Buffett urge companies to consider no longer providing quarterly earnings guidance.
As futures point higher, these are the headlines you need to get up to speed during your morning commute.
Tech and retail gains aren't enough to lead markets to new highs.
DUBLIN, June 5, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today issued the following statement in response to a public shareholder letter: Allergan's board of directors and management welcome input from all our shareholders, and take into account...
Jim discusses Constellation Brands, Goldman Sachs and a new position in Salesforce.com.
The 'Hold on to Hope' movement takes to social media in recognition of Alzheimer's & Brain Awareness during the month of June
Jim discusses our decision to exit Allergan, the AAP Bullpen, Apple's upcoming Worldwide Developers Conference and more!
After a lot of patience and disappointment, we are closing our remaining small 'spec' position.
Markets go through a short and volatile week.
They may not get all the attention, but antibiotic drugs are increasingly important.
Following up on a pledge to accelerate generic drugs into the marketplace to stoke price competition, the agency signals pending reform of the Risk Evaluation and Mitigation Strategy.
Here's what you need to know now for Wednesday, May 30.
--Allergan-Sponsored Survey Of Latina Influencers Reveals One In Two Respondants Favor Complementing Diet And Exercise With Non-Surgical Body Contourng Treatments Such As Coolsculpting® [1]--
Company's plans to sell two small units are largely a cosmetic fix.
